Agreement signedPublished 20 Feb 2025
AstraZeneca /
FibroGen International
AstraZeneca agrees to buy FibroGen International




01 / BuyerAstraZeneca
02 / SellerFibroGen China Anemia Holdings, Ltd.
03 / TargetFibroGen International
Source-verifiedWhat happened
AstraZeneca agreed to acquire FibroGen International for approximately $160 million, according to a filing dated Feb. 20, 2025.
The source
Everything on this page comes from the source below.
01
Source · Original source
AstraZeneca agrees to buy FibroGen International
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly